e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Treatment strategies, systemic manifestations and biomarkers in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time
P. B. Udesen, C. Porsbjerg, C. G. Westergaard, V. Backer (Copenhagen NV, Denmark)
Source:
Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Session:
Treatment strategies, systemic manifestations and biomarkers in airway diseases
Session type:
Thematic Poster Session
Number:
4052
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. B. Udesen, C. Porsbjerg, C. G. Westergaard, V. Backer (Copenhagen NV, Denmark). Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time. Eur Respir J 2011; 38: Suppl. 55, 4052
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine
Source: Eur Respir J 2006; 28: Suppl. 50, 678s
Year: 2006
Increased airway closure is a determinant of airway hyperresponsiveness
Source: Eur Respir J 2008; 32: 1563-1569
Year: 2008
Airway remedeling in a mouse model of chronic asthma: relation between the degree of airway remodeling and airway hyperresponsiveness
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004
Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma
Source: Eur Respir J 2001; 18: 444-450
Year: 2001
Airway inflammation in symptomatic and asymptomatic subjects with and without airway hyperresponsiveness
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001
Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 310s
Year: 2002
Markers of inflammation and airway responses to allergen in asthmatic patients
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
Airway inflammation and airway pathophysiology in older asthmatics
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
The association between airway hyperresponsiveness to mannitol and T2 inflammatory markers in asthma versus COPD
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
The burden of airway hyperresponsiveness on the control of asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice
Source: Eur Respir J 2008; 32: 970-978
Year: 2008
Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness
Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation
Year: 2006
The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003
Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014
Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011
Allergen-induced nonspecific bronchial hyperresponsiveness in patients with intermittent asthma
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009
Correlation between bronchial hyperresponsiveness and bronchial inflammation in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept